ArticleCancer medicine2023

MET kinase inhibitor reverses resistance to entrectinib induced by hepatocyte growth factor in tumors with NTRK1 or ROS1 rearrangements.

Yohei Takumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.